Haemonetics Corp. (hae 2.5 06/01/29)

13F holders, Q4 2025 (December 31)
10holders +3
3new positions
0sold out
$1.04avg. 13F price*

At the end of Q4 2025, 10 institutions reported holding Haemonetics Corp. (hae 2.5 06/01/29) in their 13F filings, up 3 from Q3 2025. 3 opened new positions and 0 sold out. The largest holders were Income Research & Management ($3.4M), State of Wisconsin Investment Board ($3.1M) and New York State Common Retirement Fund ($1.4M).

Company
Haemonetics Corp. (hae 2.5 06/01/29)
CUSIP
405024AD2
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q2 2025: 6Q2 2025Q3 2025: 7Q3 2025Q4 2025: 10Q4 2025Q1 2026: 10Q1 2026Q2 2026: 12Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions3$33K
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 367,175 shares bought and 2,673,000 shares sold, net −2,305,825 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Income Research & Management 1.79% Add +4.0% 3,270,000 $3.4M
State of Wisconsin Investment Board 0.01% No change 3,000,000 $3.1M
New York State Common Retirement Fund 0.00% Reduce -66.6% 1,340,000 $1.4M
Bank of New York Mellon Corp 0.00% Add +30.0% 650,000 $676K
Cetera Investment Advisers 0.00% Add +177.4% 86,000 $89K
&partners 0.00% No change 79,000 $82K
Choreo, LLC 0.00% Add +17.9% 33,000 $34K
Foresight Capital Management Advisors, Inc. 0.02% New 27,000 $28K
Comerica Bank 0.00% New 5,000 $5K
Oddo BHF Asset Management Sas 0.00% New 175 $182

"% of holder's portfolio" is HAEMONETICS CORP (HAE 2.5 06/01/29)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 2.5 06/01/29) the manager owns.